Artificial Intelligence | News | Insights | AiThority
[bsfp-cryptocurrency style=”widget-18″ align=”marquee” columns=”6″ coins=”selected” coins-count=”6″ coins-selected=”BTC,ETH,XRP,LTC,EOS,ADA,XLM,NEO,LTC,EOS,XEM,DASH,USDT,BNB,QTUM,XVG,ONT,ZEC,STEEM” currency=”USD” title=”Cryptocurrency Widget” show_title=”0″ icon=”” scheme=”light” bs-show-desktop=”1″ bs-show-tablet=”1″ bs-show-phone=”1″ custom-css-class=”” custom-id=”” css=”.vc_custom_1523079266073{margin-bottom: 0px !important;padding-top: 0px !important;padding-bottom: 0px !important;}”]

Clinion and Clinevo’s Strategic Alliance for An Integrated eClinical Experience

AI-powered eClinical Platform, Clinion, announces strategic partnership with eClinical safety solutions provider, Clinevo.

Clinion, a leading eClinical solutions provider, announced a strategic partnership with Clinevo, an industry leader in eClinical safety solutions. This collaboration brings together Clinion’s AI-enabled eClinical platform with Clinevo’s eTMF and Safety solutions, offering a fully integrated seamless end-to-end eClinical solution. Latest News: Arista Unveils Etherlink AI Networking Platforms

Through this collaboration, Clinion now offers Clinevo’s eTMF and Safety solutions alongside our existing suite of products. Similarly, Clinevo now will be able to offer Clinion’s comprehensive EDC, RTSM, CTMS, ePRO, and eConsent solutions to their user base.
Customers would now be able to access both Clinion and Clinevo products on one platform, improving data quality and reducing integration challenges and trial timelines.

Clinevo’s eTMF and Safety solutions are designed to enhance regulatory compliance and streamline safety reporting, making them an ideal complement to Clinion’s robust suite of eClinical tools. This partnership reflects a shared commitment to innovation and excellence in clinical trial management.

Related Posts
1 of 40,583

“We are excited to partner with Clinevo to expand our portfolio and deliver even greater value to our customers, By combining our strengths, we can offer a more holistic eClinical experience that streamlines clinical trials, improves data accuracy, and accelerates the development of new therapies” said Manuj Vangipurapu, CEO of Clinion.

“We are delighted to join forces with Clinion to provide AI enabled end-to-end Integrated Clinical Solutions to our Customers, Their innovative EDC, CTMS, RTSM, and ePRO solutions are a perfect match for our eTMF and Pharmacovigilance & Drug Safety offerings. Together, we can provide a seamless and integrated eClinical experience that supports our clients in conducting efficient and compliant clinical trials.” said Arunkumar Devaraj, Director of Clinevo. Latest News: Unbabel Releases TowerLLM, the First AI Model to Surpass GPT-4o, GPT-3.5 in Machine Translation

This strategic partnership represents a significant step forward for both Clinion and Clinevo, positioning them as leaders in the eClinical solutions market. By leveraging each other’s strengths, the companies aim to enhance the efficiency and effectiveness of clinical trials, ultimately benefiting Sponsors, CROs and Patients alike. Latest News: Quantexa Partners with Databricks to Accelerate Customer Data and AI Initiatives

[To share your insights with us as part of editorial or sponsored content, please write to]

Comments are closed.